AEON Biopharma issues 4.7M shares in partial over-allotment exercise, raising $1.5M gross

AEON Biopharma, Inc.

On July 23, 2026, issued 4,696,102 shares of Class A common stock to underwriters.
Gross proceeds of approximately $1.5 million; net proceeds of ~$1.4 million after underwriting discounts.
Partial exercise of over-allotment option; previous full exercise for warrants to purchase 6,403,290 shares.
Offering originally completed July 15, 2026, with Lake Street Capital Markets as representative.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.